Systemic lupus erythematosus (SLE) is a typical autoimmune connective tissue disease with complex pathogenesis and diverse clinical symptoms, which brings challenges to the diagnosis and monitoring of SLE. Metabonomics, as an emerging omics technology in the post gene era, provides new strategies and new ideas for finding new biomarkers.